This topic contains a solution. Click here to go to the answer

Author Question: Which of the following behaviors would most likely increase the risk of developing cancer? A) ... (Read 63 times)

jrubin

  • Hero Member
  • *****
  • Posts: 552
Which of the following behaviors would most likely increase the risk of developing cancer?
 
  A) training and participating in a 10K race
  B) increasing your BMI by using weight training to build muscle
  C) eating a diet high in empty calories
  D) taking a stress management class

Question 2

Which of the following is TRUE about radiation and cancer?
 
  A) Ionizing radiation has been proven safe.
  B) Ionizing radiation is the only form of radiation proven to cause cancer.
  C) Exposure to radon has not been shown to increase the risk of cancer.
  D) Ultraviolet radiation exposure does not increase cancer risk.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

iman

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

Answer: C

Answer to Question 2

Answer: B




jrubin

  • Member
  • Posts: 552
Reply 2 on: Jul 12, 2018
:D TYSM


Joy Chen

  • Member
  • Posts: 354
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

More than 34,000 trademarked medication names and more than 10,000 generic medication names are in use in the United States.

Did you know?

About 3.2 billion people, nearly half the world population, are at risk for malaria. In 2015, there are about 214 million malaria cases and an estimated 438,000 malaria deaths.

Did you know?

Serum cholesterol testing in adults is recommended every 1 to 5 years. People with diabetes and a family history of high cholesterol should be tested even more frequently.

Did you know?

Amphetamine poisoning can cause intravascular coagulation, circulatory collapse, rhabdomyolysis, ischemic colitis, acute psychosis, hyperthermia, respiratory distress syndrome, and pericarditis.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library